Page 1218 - Adams and Stashak's Lameness in Horses, 7th Edition

1184 Index

arthritis, traumatic arthritis: multiple BA (betamethasone), intrasynovial bone marrow‐derived mesenchymal stem
manifestations, 808–809 back therapies, 888 cells (BMSCs), intrasynovial
therapies, 891
VetBooks.ir arthrosis see also axial; thoracolumbar spine/back bone tumors, 840
arthrography, 198
botulism, 1180
carpus, racing Quarter horses, 977
back problems, thermography, 436–438
bursitis of the elbow (olecranon bursitis),
distal interphalangeal (DIP) joint, racing
palpation and manipulation, 113–114, 116
Quarter horses, 975
632–633
articular cartilage and subchondral bone back pain clinical signs, 633
jumping/eventing/dressage, 994–995
surface, ultrasonography, 328 dorsal spinous process impingement, diagnosis, 633
articular cartilage metabolism and matrix 994–995 etiology, 633
turnover, 806–807 intervertebral thoracolumbar facet prognosis, 633
articular cartilage repair, 814–816 OA, 995 treatment, 633
articular cartilage structure and function, kissing spines, 994–995 buttress foot, foot conformation, 91
803–806 primary muscle strain and or spasm, 994
biomechanics, 806 suboptimal saddle fit creating pressure calcaneal bursa, intrasynovial anesthesia,
cartilage nutrition and innervation, 805 points or restricting the horse’s 183, 184
collagens, 803–804 movement, 994 calcinosis circumscripta (tumoral
glycoproteins, 805 balance, examination for lameness, 74–76 calcinosis), 844
proteoglycans, 804–805 base‐narrow, toe‐in conformation, forelimb femur, 749–750
As Low As Reasonably Achievable (ALARA), conformation, 82 clinical signs, 749
nuclear medicine, radiation safety and base‐narrow, toe‐out conformation, forelimb diagnosis, 749
protection, 343 conformation, 82 etiology, 749
autologous bone marrow aspirate (ABMA), base‐narrow comformation, forelimb prognosis, 750
intralesional therapies, 896–898 conformation, 81 treatment, 749–750
autologous cell therapies: mesenchymal base‐narrow conformation, hindlimb capital physeal fractures of the femoral
stem cell therapy, autologous bone conformation, 89 head, 758
marrow aspirate, tendon‐derived base‐wide, toe‐out conformation, forelimb clinical signs, 758
progenitor cells, intralesional conformation, 82–83 diagnosis, 758
therapies, 896–897 base‐wide conformation, forelimb etiology, 758
autologous conditioned serum (ACS), conformation, 81 prognosis, 758
intrasynovial therapies, 890 bench knees (offset knees), forelimb treatment, 758
autologous protein solution (APS) conformation, 84 carpal bones, radiography, 212, 253–256
intralesional therapies, 897–898 betamethasone (BA), intrasynovial carpal flexion, palpation and
intrasynovial therapies, 891 therapies, 888 manipulation, 117
avocado and soybean unsaponifiable bicipital bursitis (intertubercular bursa) carpal joints, intrasynovial anesthesia,
extracts, nutraceuticals, 906 inflammation, 641–643 176–178
avulsion injuries of the hoof, 485–489 clinical signs, 641 carpal region
clinical signs, 486 conservative treatment, 642–643 magnetic resonance imaging (MRI),
diagnosis, 486 diagnosis, 641–642 420–421
etiology, 486 etiology, 641 osseous and osteochondral
prognosis, 489 prognosis, 643 pathology, 421
treatment, 486–489 surgical treatment, 643 soft tissue injuries, 421
axial treatment, 642–643 carpometacarpal osteoarthritis, 616, 617
see also back bilateral lameness, kinematics (measurement carprofen see nonsteroidal anti‐inflammatory
axial components of movement), 153 drugs
functional anatomy, 60–64 bisphosphonates, 877 carpus, 597–619
caudal vertebrae, 62 distal tarsal (DT) joints/DT joint pain, accessory carpal bone fracture, 612–613
cervical vertebrae, 61 osteoarthritis (OA), 668 clinical signs, 612
ligamentum nuchae, 63 blocking effect, kinematics (measurement of diagnosis, 612
lumbar vertebrae, 61–62 movement), 150–151 etiology, 612
muscles of the trunk and neck, 63–64 blood‐derived biologics: platelet‐rich plasma, prognosis, 612
sacroiliac region, 62–63 autologous conditioned serum, treatment, 612
sacrum, 62 autologous protein solution, and bone angular limb deformities (ALDs), 598–603
thoracic vertebrae, 61 marrow aspirate, intralesional clinical signs, 599–600
vertebral articulations, 62 therapies, 897–898 diagnosis, 599–600
vertebral column, 60–61 BMSCs (bone marrow‐derived diagnostic imaging, 600
axial osteitis/osteomyelitis of the proximal mesenchymal stem cells), etiology, 598–599
sesamoid bones, 549–550 intrasynovial therapies, 891 prognosis, 603
clinical signs, 549–550 bone transphyseal bridging, 602–603
diagnosis, 549–550 medication effects, 846 treatment, 600–603
etiology, 549 nuclear medicine arthrosis of the carpus, racing Quarter
prognosis, 550 abnormal conditions, 361–372 horses, 977
treatment, 550 normal bone scan, 348–356 common digital extensor tendon rupture,
axial skeleton, 763–768 radiography, 200–206 604–605
anatomy and biomechanics of the vertebral cortical changes, 201–202, 203, 204 clinical signs, 605
column, 763–767 fundamental patterns of bone response, diagnosis, 605
canter, 764 200–201 etiology, 604–605
clinical examination, 766–767 osteomyelitis, radiographic signs (bone prognosis, 605
history, 764–765 response patterns), 203–206 treatment, 605
mobility of the spine, 764 periosteal reactions, 201 desmitis of the accessory ligament (radial
symptoms and locations, 765 trabecular bone, 203, 204, 205 or superior check ligament) of the
trot, 764 ultrasonography, bone evaluation, 332 superficial digital flexor tendon, 619
walk, 764 bone contusion/bruising/periostitis, 840–841 clinical signs, 619
primary vs. secondary back pain, bone contusions, stifle region, magnetic diagnosis, 619
767–768 resonance imaging (MRI), 425 etiology, 619
western pleasure horses, 1013 bone cysts, 839, 840 prognosis, 619
axial skeleton pain, jumping/eventing/ bone evaluation, ultrasonography, 332 treatment, 619
dressage, 994–995 bone fragility disorder, 843 developmental abnormalities, 598–604